Antianxiety activity of methanol extract of Gelsemium sempervirens (Linn.)Ait

Автор: Garg Vandana, Dhar V.J., Sharma Anupam, Dutt Rohit

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 2 т.8, 2012 года.

Бесплатный доступ

Background: Despite significant advances in understanding and management of neuropsychiatric disorders during past few decades, anxiety and depression, still remains the leading cause of deaths, primarily for want of effective and safe treatment of these ailments. Approximately, two third of the anxious or depressed patients respond to the currently available treatment but the magnitude of improvement is still disappointing Purpose of Study: The aim of the present study was to investigate the antianxiety activity of Gelsemium sempervirens (Linn.) Ait. Various doses (50,100, 150, 200mg/kg) of plant extracts viz., of petroleum ether, chloroform, methanol and water were administered orally to Swiss Albino Mice before evaluating their behavioural pattern. Diazepam (2.5 mg/kg) was used as standard drug. Result: The methanol extract of G. sempervirens (150 mg/kg) increased the mean time spent, mean number of arms entries in the open arms of elevated plus maze (EPM) and decreased the mean time spent in the closed arms. The locomotor activity of methanol extract was not affected to the same extent as observed for diazepam. Conclusion: The results suggested that methanol extract of G. sempervirens possess anxiolytic effects with no sedative activity when compared to diazepam.

Еще

Anxiolytic, elevated plus maze test, gelsemium sempervirens, yellow jasmine

Короткий адрес: https://sciup.org/14323600

IDR: 14323600

Список литературы Antianxiety activity of methanol extract of Gelsemium sempervirens (Linn.)Ait

  • Barbotte, E., Guillemin, F., Chan, N., (2001) Prevalence of impariment, disablilites, handicaps, and quality of life in the general population: a review of recent literature. Int. J. Public Health (Bulletin of World Health Organisation), 79, 1047-1055
  • Bassleer, R., Clerment, D., Marnette, J.M., Caprasse, M., Tits, M. and Angenot, L., (1985) Effect of dihydroflavopiperine and sempervirens (?-carbolinium alkaloids) on cancer cells in culture, Ann. Pharm. Fr., 83-88.
  • Bousta, D., Soulimani, R., Jarmouni, I., Belon, P., Falla, J., Froment, N., Younos, C., (2001) Neurotropic, immunological and gastric effects of low doses of Atropa belladonna L., Gelsemium sempervirens L. and Poumon histamine in stressed mice. J of Ethnopharmacol 74, 205-215
  • Chopra R.N. (1940). Poisonous Plants of India Vol.1 Council of Agriculture Research. 692-693.
  • Chou, T.A. (1931) The alkaloids of Gelsemium I. Gelsemine and gelsemicine, Zhongguo Shenglixue Zazhi, 5, 131-139.
  • Christmas, D.M., Hood, S.D., (2006) Recent development in anxiety disorders. Recent Pat. on CNS Drug Disco. 1(3), 289-298
  • Ferrerio, M. (1945) The alkaloids of Gelsemium sempervirens (Linn.)Ait. (Loganiaceae), Anal. Sci. Nat. Bot.,1945,, 148-153.
  • Fransworth, N.R. (1966) Biological and phytochemical screening of plants, J. Pharm. Sci., 55, 225-286.
  • Ghosh M. N. (1984) Fundamental of Experimental Pharmacology, Scientific Book Agency, Kolkata, 2nd edition 156-157.
  • Grieve, M (1994). A Modern Herbal, International Tiger Books, London. 249-250.
  • Janot, M.M., Gautarol, R. and Friedrich W. (1951) Gelsemicine, Ann. Pharm. Fr., 9, 305-307.
  • Jensen, S.R., Kirk, O., Nielsen, B. J. and Norrestam R. (1987). 9-hydroxy substituted iridiods from Gelsemium sempervirens, Phytochem,. 26, 1725-1731.
  • Jordan, A.D., Kordik, C.P., Reitz, A.B. and Sanfillopo, P.J. (1996) Novel anxiolytic agents 1994 to present. Expert Opin. Ther. Pat. 6, 1047-1060.
  • Kim, J.H., Kim, S.Y. Lee, S.Y., Jang, C.G., (2007) Antidepressant like effects of Albizzia julibrassin in mice: involvement of 5-HT 1A receptors system. Pharmacol. Biochem. and Behav. 87, 41-47
  • Nikiforov, A., Latzel, J., Varmuza, K. and Wichtl, M: (1974) Gelsemium alkaloids structure elucidation of 21-oxogelsemine by mass spectrometry, Montashefte Feur Chemie., 105, 1292-1298.
  • Pellow, S., Chopin, P., File, S.E. and Bradley M. (1986) Validation of open: enclosed arm entries in elevated plus maze as a measure of anxiety in rats. J. Neurosci. Methods, 14, 149-156.
  • Reynolds, E.H., (2003). Brain and mind: a challenge for WHO. Lancet 361, 1924-1925
  • Rickels, K. and Schweizer, E. (1997) The clinical presentation of generalized anxiety in primary care setting practical concepts of classification and management. J. Clin. Psychiatry 58, 4-9.
  • Rickels, K., Schweizer, E., Case, W.G., Greenblatt, D.J., (1990) Long terms therapeutics use of benzodiazepines. I. effects of abrupt discontinuation. Arch. Gen. Psychiatry 47, 899-907.
  • Rothlin, E. and Raymond, H., (1934) Vascular action of sempervirens, an oxygen free alkaloids of Gelsemium Sempervirens. Computes Rendus des Seances de la Societe de Biologie et de Filiales, 117, 754-756.
  • Rybnikova, E., Mironova, V., Pivina, S., Tulkova, E., Ordyan, N., Vataeva, L., Vershinina, E., Abritalin, E., Kolchev, A., Nalivaeva N., Turner, A.J., Samoilov, M. (2007) Antidepressant-like effects of mild hypoxia preconditioning in the learned helplessness model in rats. Neurosci. lett. 417, 234-239.
  • Sayre, L.E. (1911) Gelseminine and other constituents of Gelsemium. P'ceutics J., 86, 242-243.
  • Schun, Y. and Cordell, G.A. (1987) Cytotoxic steroids of Gelsemium sempervirens J. Nat. Prod.50, 195-198.
  • Vogel G.H. and Vogel W.H: Drug discovery and evaluation, Springer Verlang, Berlin, 1998, 413-414.
  • Voorhees, J., Nachman, L., (2002) Herbal composition for treating symptoms of influenza. US Patent No. 6455070, 3 pp. Through Chemical Abstract 137, 159364 (2002).
  • Wang, Y., Fang, Y., Lin, W., Cheng, M., Jiang, Y. and Yin, M. (2001) Inhibitory effects of Gelsemium alkaloids extract on hepatic carcinoma HepG2 cells in vitro, J. Chine. Med. Materl., 24, 579-.581.
  • Wenkert, E., Chang, C.J. and Corchan, D.W., Polliccari R. (1972) 13C nuclear magnetic resonance spectroscopy of naturally occurring substances VIII Structure of gelsevirine. Experientia,28, 377-379.
  • Zwanzger, P., Eser, D., Rupprecht, R., (2007) Anticonvulsant in the treatment of anxiety-an alternative treatment option? Nervenarzt, 78 (11) 1274-1282
Еще
Статья научная